Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance

Hepatology

Volumn 29, Issue 1, 1999, Pages 230-237

  Pichoud, Christian ^a   Seigńres, Béatrice ^a   Wang, Zhirui ^a,c   Trépo, Christian ^a,b   Zoulim, Fabien ^a,b  

^a INSERM   (France)

^b HÔTEL DIEU   (France)

^c KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAMCICLOVIR; LAMIVUDINE; PENCICLOVIR;

ADULT; AMINO ACID SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CASE REPORT; DRUG EFFICACY; GENE MUTATION; GENETIC TRANSFECTION; HEPATITIS B; HEPATOMA CELL; HUMAN; MALE; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROCONVERSION; STRUCTURAL GENE; VIRUS REPLICATION;

2-AMINOPURINE; ADULT; AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; CELLS, CULTURED; CLONING, MOLECULAR; DNA-DIRECTED DNA POLYMERASE; DRUG RESISTANCE, MICROBIAL; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOCOMPETENCE; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PRODRUGS; TRANSFECTION; VIRUS REPLICATION;

EID: 0032897955     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290119     Document Type: Article

References (26)

1. Zoulim F, Trépo C. Drug therapy for chronic hepatitis B: Antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy. J Hepatol 1998;29:151-168.
2. Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347-356.
3. Lin E, Luscombe C, Wang Y, Shaw T, Locamini S. The guanine nucleoside analog penciclovir is active against chronic duck hepatitis B virus infection in vivo. Antimicrob Agents Chemother 1996;40:413-418.
4. Shaw T, Amor P, Civitico G, Boyd M, Locarnini S. In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus. Antimicrob Agents Chemother 1994;38:719-723.
5. Shaw T, Mok S, Locarnini S. Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir. HEPATOLOGY 1996;24:996-1002.
6. Dannaoui E, Trépo C, Zoulim E Inhibitory effect of penciclovir-triphosphate on duck hepatitis B virus reverse transcription. Antivir Chem Chemother 1997;8:38-46.
7. Main J, Brown J, Howells C, Galassini R, Crossey M, Karayiannis P, Georgiou P, et al. A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection. J Viral Hepatitis 1996;3:211-215.
8. Krüger M, Tillmann H, Trautwein C, Oldhafer K, Boker K, Pichlmayr R, Manns M. Famciclovir treatment of hepatitis B virus recurrence after orthotopic liver transplantation. A pilot study. (Abstract). HEPATOLOGY 1995;22:219A.
9. Trépo C, Jezek P, Atkinson G, Boon R. Efficacy of famciclovir in chronic hepatitis B: results of a dose finding study. (Abstract). HEPATOLOGY 1996;24:188A.
10. Nowak M, Bonhoeffer S, Hill A, Boehme R, Thomas H, McDade H. Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci USA 1996;93:4398-4402.
11. Dienstag J, Perillo R, Schiff E, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995;333:1657-1661.
12. Lai C-L, Ching C-K, Tung AK-M, Li E, Young J, Hill A, Wong B C-Y., et al. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. HEPATOLOGY 1997;25:241-244.
13. Arts E, Wainberg M. Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription. Antimicrob Agents Chemother 1996;40:527-540.
14. Xiong Y, Eickbush T. Origin and evolution of retroelemenls based upon their reverse transcriptase sequence. EMBO J 1990;9:3353-3362.
15. Kohlstaedt LA, Wang J, Friedman JM, Rice PA, Steitz TA. Crystal structure at 3.5 A resolution if HIV-1 reverse transcriptase complexed with an inhibitor. Science 1992;256:1783-1790.
16. Bartholomeusz A, Locarnini S. Mutations in the hepatitis B virus polymerase gene that are associated with resistance to famciclovir and lamivudine. International Antiviral News 1997;5:123-124.
17. Bartholomew M, Jansen R, Jeffers L, Reddy K, Johnson L, Bunzendahl H, Condreay LD, et al. Hepatitis B virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 1997; 349:20-22.
18. Ling R, Mutimer D, Ahmed M, Boxall EH, Elias E, Dusheiko GM, Harrison TJ. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. HEPATOLOGY 1996;24:711-713.
19. Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrell DL. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. HEPATOLOGY 1996;24:714-717.
20. Honkoop P, Niesters HGM, de Man RAM, Osterhaus ADME, Schalm SW. Lamivudine resistance in immunocompetent chronic hepatitis B: incidence and patterns. J Hepatol 1997;26:1393-1395.
21. Lai CL, Chien RN, Leung NWY, Chang TT, Guan R, Tai DI, Ng KY, et al. A one year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998;339:61-68.
22. Perillo R, Rakela J, Martin P, Levy G, Schiff E, Wright T, Dienstag J, et al. Long-term lamivudine therapy of patients with recurrent hepatitis B post-liver transplantation. (Abstract). HEPATOLOGY 1997;26(Suppl): A196.
23. Aye TT, Bartholomeusz A, Shaw T, Bowden S, Breschkin A, McMillan J, Angus P, et al. Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation. J Hepatol 1997:1148-1153.
24. Locamini SA, Aye TT, Shaw T, De Man R, Angus PW, McCaughan GW, Bartholomeusz A. The emergence of famciclovir resistant mutations in the hepatitis B virus polymerase during therapy following liver transplantation. (Abstract). HEPATOLOGY 1997;26(Suppl):A958.
25. Tillmann HL, Trautwein C, Bock T, Glowenka M, Krüger M, Bōker K, Jāckel E, et al. Response and mutations in patients sequentially treated with lamivudine and famciclovir for recurrent hepatitis B after liver transplantation. (Abstract). HEPATOLOGY 1997;26(Suppl):A1202.
26. Zhang X, Zoulim F, Habersetzer F, Xiong S, Trépo C. Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B. J Med Virol 1996;48:8-16.